Prospective Study of Neuropsychiatric Events in Systemic Lupus Erythematosus

JOHN G. HANLY,LI SU,VERN FAREWELL,GRACE McCURDY,LISA FOUGERE,KARA THOMPSON
DOI: https://doi.org/10.3899/jrheum.081133
2009-05-15
The Journal of Rheumatology
Abstract:Objective. To prospectively examine neuropsychiatric (NP) events and their association with health related quality of life (HRQOL) over time in patients with systemic lupus erythematosus (SLE). Methods. In an observational cohort study from a single academic center, NP events and their attribution were identified at enrollment and at annual assessments for up to 7 years. NP events were characterized using the American College of Rheumatology case definitions; other variables were global SLE disease activity and cumulative organ damage. The outcomes of NP events were recorded and self-report HRQOL was measured with the mental (MCS) and physical (PCS) component summary scores of the Medical Outcomes Study Short Form-36. Results. There were 209 patients, 88% female and 92% Caucasian, with a mean (standard deviation) age of 43.7 (13.8) years. Followup was available in 175/209 (84%) patients. There were 299 NP events in 132/209 (63%) patients over a mean followup of 3.6 (2.5) years. Thirty-one percent of NP events in 54 patients were attributed to SLE. Multivariate analysis indicated lower MCS scores in patients with NP events compared to those without events (p < 0.001) regardless of attribution. The group means for PCS scores were significantly lower in patients with NP events (p < 0.001) regardless of attribution. There was no association between HRQOL and cumulative organ damage, nor between NP events and the progression of organ damage. Conclusion. The association of lower HRQOL with NP events over time, which is independent of progression in cumulative organ damage, emphasizes the persistent negative effect of NP events in the lives of patients with SLE.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the long - term outcomes of neuropsychiatric events (NP events) in patients with systemic lupus erythematosus (SLE) and their impact on health - related quality of life (HRQOL). Specifically, the researchers hope: 1. **Prospectively examine NP events**: In SLE patients, through a follow - up of up to 7 years, observe the occurrence of NP events and their attribution (that is, whether these events are related to SLE or caused by other non - SLE factors). 2. **Evaluate the impact of NP events on HRQOL**: Study the impact of NP events on the physical and mental health of patients (measured by the Mental Component Summary score MCS and the Physical Component Summary score PCS of the SF - 36 scale). 3. **Explore the relationship between NP events and cumulative organ damage**: Analyze whether NP events are related to the progression of cumulative organ damage in SLE patients. Through these objectives, the researchers aim to comprehensively understand the incidence, attribution of NP events in SLE patients and their long - term impact on the quality of life of patients, so as to provide a basis for clinical management and treatment.